标题
The roles and regulation of MDM2 and MDMX: it is not just about p53
作者
关键词
-
出版物
GENES & DEVELOPMENT
Volume 35, Issue 9-10, Pages 575-601
出版商
Cold Spring Harbor Laboratory
发表日期
2021-04-22
DOI
10.1101/gad.347872.120
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Small‐molecule MDM2 inhibitor LQFM030‐induced apoptosis in p53‐null K562 chronic myeloid leukemia cells
- (2020) Higor de Oliveira Ribeiro et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling
- (2020) Divya Venkatesh et al. GENES & DEVELOPMENT
- Long non‐coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR‐363‐3p
- (2020) Hao Rong et al. Thoracic Cancer
- Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
- (2020) Yuan Fang et al. Acta Pharmaceutica Sinica B
- Mdm2 – open questions
- (2020) Matthias Dobbelstein et al. CANCER SCIENCE
- Genome-wide association study identifies zonisamide responsive gene in Parkinson’s disease patients
- (2020) Pei-Chieng Cha et al. JOURNAL OF HUMAN GENETICS
- CircularRNA-9119 promotes the proliferation of cervical cancer cells by sponging miR-126/MDM4
- (2020) Yonghui Tian et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Mdm4 supports DNA replication in a p53-independent fashion
- (2020) Kai Wohlberedt et al. ONCOGENE
- SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle
- (2020) Ya-Fei Lu et al. ONCOGENE
- The p53/MDM2/MDMX-targeted therapies—a clinical synopsis
- (2020) Liren Jiang et al. Cell Death & Disease
- Structural basis for DNA damage-induced phosphoregulation of MDM2 RING domain
- (2020) Helge M. Magnussen et al. Nature Communications
- MDM2-Mediated Ubiquitination of ACE2 Contributes to the Development of Pulmonary Arterial Hypertension
- (2020) Hui Shen et al. CIRCULATION
- Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression
- (2019) Koji Nakamura et al. Oncotarget
- Evidence for an Integrated Gene Repression Mechanism Based on mRNA Isoform Toggling in Human Cells
- (2019) Ina Hollerer et al. G3-Genes Genomes Genetics
- DBC1 Regulates p53 Stability via Inhibition of CBP-Dependent p53 Polyubiquitination
- (2019) Oluwatoyin E. Akande et al. Cell Reports
- miRNA‑766 induces apoptosis of human colon cancer cells through the p53/Bax signaling pathway by MDM4
- (2019) Weirong Chen et al. Experimental and Therapeutic Medicine
- MDM2 promotes genome instability by ubiquitinating the transcription factor HBP1
- (2019) Zhengyi Cao et al. ONCOGENE
- MDM2 Integrates Cellular Respiration and Apoptotic Signaling through NDUFS1 and the Mitochondrial Network
- (2019) Rana Elkholi et al. MOLECULAR CELL
- Mdm2 is required for HDAC3 monoubiquitination and stability
- (2019) Yeong Min Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Oncogenic effect of PHLDB2 is associated with epithelial–mesenchymal transition and E-cadherin regulation in colorectal cancer
- (2019) Geng Chen et al. Cancer Cell International
- miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression
- (2019) Kehua Jiang et al. Molecular Genetics & Genomic Medicine
- CircSAMD4A accelerates cell proliferation of osteosarcoma by sponging miR-1244 and regulating MDM2 mRNA expression
- (2019) Zhao Yanbin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53
- (2019) Wei Wang et al. CANCER LETTERS
- Targeting MDM2 for novel molecular therapy: Beyond oncology
- (2019) Wei Wang et al. MEDICINAL RESEARCH REVIEWS
- SRSF2 Regulation of MDM2 Reveals Splicing as a Therapeutic Vulnerability of the p53 Pathway
- (2019) Daniel F. Comiskey et al. MOLECULAR CANCER RESEARCH
- miR-1305 Inhibits The Progression Of Non-Small Cell Lung Cancer By Regulating MDM2
- (2019) Yuxing Cai et al. Cancer Management and Research
- Mdm2 is a target and mediator of IRP2 in cell growth control
- (2019) Jin Zhang et al. FASEB JOURNAL
- Inhibition of Noncanonical Mouse Double Minute 2 Homolog Abrogates Ocular Inflammation through NF-κB Suppression
- (2018) Yan Fan et al. AMERICAN JOURNAL OF PATHOLOGY
- Nutlin sensitizes lung carcinoma cells to interferon-alpha treatment in MDM2-dependent but p53-independent manner
- (2018) Oleg Shuvalov et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling
- (2018) Debanjan Dhar et al. CANCER CELL
- Peli1 Modulates the Subcellular Localization and Activity of Mdmx
- (2018) Dawei Li et al. CANCER RESEARCH
- Regulation of the Mdm2–p53 pathway by the ubiquitin E3 ligase MARCH7
- (2018) Kailiang Zhao et al. EMBO REPORTS
- Dysregulation of Mdm2 and Mdm4 alternative splicing underlies motor neuron death in spinal muscular atrophy
- (2018) Meaghan Van Alstyne et al. GENES & DEVELOPMENT
- Suppression of IKK, but not activation of p53 is responsible for cell death mediated by naturally occurring oxidized tetranortriterpenoid
- (2018) Pankaj Gupta et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- LQFM030 reduced Ehrlich ascites tumor cell proliferation and VEGF levels
- (2018) Mariana Flavia da Mota et al. LIFE SCIENCES
- Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53
- (2018) Giuseppe Arena et al. MOLECULAR CELL
- Inhibition of Mdmx (Mdm4) in vivo induces anti-obesity effects
- (2018) Ning Kon et al. Oncotarget
- Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection
- (2018) Andrés Pizzorno et al. Scientific Reports
- MDM4 contributes to the increased risk of glioma susceptibility in Han Chinese population
- (2018) Peng Sun et al. Scientific Reports
- Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53
- (2018) Xinyan Wang et al. Thoracic Cancer
- Defective Replication Stress Response Is Inherently Linked to the Cancer Stem Cell Phenotype
- (2018) Daniel J. McGrail et al. Cell Reports
- Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy
- (2018) Jiang-Jiang Qin et al. Frontiers in Pharmacology
- The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways
- (2018) Hang Li et al. ACTA PHARMACOLOGICA SINICA
- The Dysfunctional MDM2-p53 Axis in Adipocytes Contributes to Ageing Related Metabolic Complications by Induction of Lipodystrophy
- (2018) Zhuohao Liu et al. DIABETES
- OUP accepted manuscript
- (2018) TOXICOLOGICAL SCIENCES
- MDM2 and Mitochondrial Function: One Complex Intersection
- (2018) Camila Rubio-Patiño et al. BIOCHEMICAL PHARMACOLOGY
- Downregulation of microRNA‐23b protects against ischemia‐reperfusion injury via p53 signaling pathway by upregulating MDM4 in rats
- (2018) Zhi Zhao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Circular RNA hsa_circ_0000263 participates in cervical cancer development by regulating target gene of miR-150-5p
- (2018) Hongning Cai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MDM2-mediated degradation of WRN promotes cellular senescence in a p53-independent manner
- (2018) Boya Liu et al. ONCOGENE
- Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication
- (2018) Ina Klusmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distinct control of PERIOD2 degradation and circadian rhythms by the oncoprotein and ubiquitin ligase MDM2
- (2018) JingJing Liu et al. Science Signaling
- Dysfunction of the MDM2/p53 axis is linked to premature aging
- (2017) Davor Lessel et al. JOURNAL OF CLINICAL INVESTIGATION
- MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
- (2017) Veronica Tisato et al. Journal of Hematology & Oncology
- The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumourigenesis
- (2017) Shunbin Xiong et al. JOURNAL OF PATHOLOGY
- HDM2 Promotes NEDDylation of Hepatitis B Virus HBx To Enhance Its Stability and Function
- (2017) Ningning Liu et al. JOURNAL OF VIROLOGY
- MDM4 actively restrains cytoplasmic mTORC1 by sensing nutrient availability
- (2017) Francesca Mancini et al. Molecular Cancer
- Inhibition of MDM2 by a Rhein-Derived Compound AQ-101 Suppresses Cancer Development in SCID Mice
- (2017) Lubing Gu et al. MOLECULAR CANCER THERAPEUTICS
- Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase
- (2017) L E Giono et al. ONCOGENE
- Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53
- (2017) J C Senturk et al. ONCOGENE
- Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function
- (2017) Naoe T. Nihira et al. Science Signaling
- Mouse modeling of the MDM2/MDMX−p53 signaling axis
- (2017) Nicole R. Tackmann et al. Journal of Molecular Cell Biology
- MBD2 upregulates miR-301a-5p to induce kidney cell apoptosis during vancomycin-induced AKI
- (2017) Juan Wang et al. Cell Death & Disease
- Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma
- (2017) Chao Wang et al. Cell Death & Disease
- MiR‑370 promotes apoptosis in colon cancer by directly targeting MDM4
- (2017) Xiaogang Shen et al. Oncology Letters
- The fate of murine double minute X (MdmX) is dictated by distinct signaling pathways through murine double minute 2 (Mdm2)
- (2017) Paula M. Hauck et al. Oncotarget
- BTK blocks the inhibitory effects of MDM2 on p53 activity
- (2017) Miran Rada et al. Oncotarget
- MDM4 genetic variants and risk of gastric cancer in an Eastern Chinese population
- (2017) Meng-Yun Wang et al. Oncotarget
- MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4
- (2017) Qingqing Wang et al. Oncotarget
- Tumorigenesis promotes Mdm4-S overexpression
- (2017) Vinod Pant et al. Oncotarget
- Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway
- (2017) Nandini Kundu et al. Oncotarget
- NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway
- (2017) Arundhati Jana et al. Oncotarget
- Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function
- (2017) Naoe T. Nihira et al. Science Signaling
- Identification of XBP1-u as a novel regulator of the MDM2/p53 axis using an shRNA library
- (2017) Can Huang et al. Science Advances
- Profile of the breast cancer susceptibility marker rs4245739 identifies a role for miRNAs
- (2017) Lukman Anwar Sumadi et al. Cancer Biology & Medicine
- MDM2 Contributes to High Glucose-Induced Glomerular Mesangial Cell Proliferation and Extracellular Matrix Accumulation via Notch1
- (2017) Chun-Tao Lei et al. Scientific Reports
- Murine Double Minute-2 Inhibition Ameliorates Established Crescentic Glomerulonephritis
- (2016) Shrikant R. Mulay et al. AMERICAN JOURNAL OF PATHOLOGY
- The Roles of MDM2 and MDMX in Cancer
- (2016) Orit Karni-Schmidt et al. Annual Review of Pathology-Mechanisms of Disease
- RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction
- (2016) Kun Gao et al. CANCER LETTERS
- 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol inhibits MDM2 and induces apoptosis in breast cancer cells through a p53-independent pathway
- (2016) Jingwen Xu et al. CANCER LETTERS
- Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer
- (2016) Anup Kumar Singh et al. CARCINOGENESIS
- PPARγ neddylation essential for adipogenesis is a potential target for treating obesity
- (2016) H-S Park et al. CELL DEATH AND DIFFERENTIATION
- Analysis of the Association between MDM4 rs4245739 Single Nucleotide Polymorphism and Breast Cancer Susceptibility
- (2016) Negar Pedram et al. Clinical Laboratory
- MDM2 Increases Drug Resistance in Cancer Cells by Inducing EMT Independent of p53
- (2016) Weichao Sun et al. CURRENT MEDICINAL CHEMISTRY
- NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
- (2016) Xiaofeng Liu et al. EMBO REPORTS
- Changes inO-LinkedN-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells
- (2016) Rafaela Muniz de Queiroz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Induction of apoptosis in Ehrlich ascites tumour cells via p53 activation by a novel small-molecule MDM2 inhibitor - LQFM030
- (2016) Mariana F. da Mota et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53
- (2016) Magdalena Wienken et al. MOLECULAR CELL
- Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53
- (2016) Romain Riscal et al. MOLECULAR CELL
- FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2
- (2016) T Liu et al. ONCOGENE
- MDM2 oligomers: antagonizers of the guardian of the genome
- (2016) P L Leslie et al. ONCOGENE
- MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation
- (2016) D-L Qi et al. ONCOGENE
- Macrophage migration inhibitory factor induces phosphorylation of Mdm2 mediated by phosphatidylinositol 3-kinase/Akt kinase: Role of this pathway in decidual cell survival
- (2016) Adriana Fraga Costa et al. PLACENTA
- The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian—but not endometrial cancer
- (2016) Liv B. Gansmo et al. TUMOR BIOLOGY
- AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX–MDM2 complex
- (2016) Anna de Polo et al. Journal of Molecular Cell Biology
- Mdm2 as a chromatin modifier
- (2016) Magdalena Wienken et al. Journal of Molecular Cell Biology
- Role of Mdm2 and Mdmx in DNA repair
- (2016) Christine M. Eischen Journal of Molecular Cell Biology
- MDM2 facilitates adipocyte differentiation through CRTC-mediated activation of STAT3
- (2016) P Hallenborg et al. Cell Death & Disease
- Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate
- (2016) Liv B. Gansmo et al. Oncotarget
- microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis
- (2016) Cen Zhang et al. Oncotarget
- Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop
- (2016) Xia He et al. Oncotarget
- USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation
- (2016) Sathish Kumar Mungamuri et al. Cell Reports
- The Evolution of the Ribosomal Protein–MDM2–p53 Pathway
- (2016) Chad Deisenroth et al. Cold Spring Harbor Perspectives in Medicine
- The Role of MDM2 Amplification and Overexpression in Tumorigenesis
- (2016) Jonathan D. Oliner et al. Cold Spring Harbor Perspectives in Medicine
- The Zn-finger domain of MdmX suppresses cancer progression by promoting genome stability in p53-mutant cells
- (2016) Z Matijasevic et al. Oncogenesis
- Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis
- (2016) Michael I. Carr et al. Translational Cancer Research
- Clinical Overview of MDM2/X-Targeted Therapies
- (2016) Andrew Burgess et al. Frontiers in Oncology
- MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer
- (2016) Reham Helwa et al. Scientific Reports
- SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
- (2015) Kanako Okamoto et al. BMC Medical Genetics
- Interaction between p53 Mutation and a Somatic HDMX Biomarker Better Defines Metastatic Potential in Breast Cancer
- (2015) A. M. Grawenda et al. CANCER RESEARCH
- WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma
- (2015) Y. Sun et al. CANCER RESEARCH
- Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
- (2015) M. Andreeff et al. CLINICAL CANCER RESEARCH
- A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer
- (2015) S. Stegeman et al. ENDOCRINE-RELATED CANCER
- The MDM2 RING Domain and Central Acidic Domain Play Distinct Roles in MDM2 Protein Homodimerization and MDM2-MDMX Protein Heterodimerization
- (2015) Patrick L. Leslie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of MDM2 Stability After DNA Damage
- (2015) Jiaqi Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Antisense oligonucleotide–mediated MDM4 exon 6 skipping impairs tumor growth
- (2015) Michael Dewaele et al. JOURNAL OF CLINICAL INVESTIGATION
- Hyperglycemia promotes p53-Mdm2 interaction but reduces p53 ubiquitination in RINm5F cells
- (2015) Barzalobre-Gerónimo Raúl et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
- (2015) Tao Liu et al. Molecular Cancer
- Requirement for human Mps1/TTK in oxidative DNA damage repair and cell survival through MDM2 phosphorylation
- (2015) Zheng-Cheng Yu et al. NUCLEIC ACIDS RESEARCH
- Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage
- (2015) Daniel F. Comiskey et al. NUCLEIC ACIDS RESEARCH
- A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer
- (2015) Feng Gao et al. PLoS One
- Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase
- (2015) Christopher N. Batuello et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting RING domains of Mdm2–MdmX E3 complex activates apoptotic arm of the p53 pathway in leukemia/lymphoma cells
- (2015) W Wu et al. Cell Death & Disease
- XI-006 induces potent p53-independent apoptosis in Ewing sarcoma
- (2015) Kathleen I. Pishas et al. Scientific Reports
- Regulation of Mutant p53 Protein Expression
- (2015) Reshma Vijayakumaran et al. Frontiers in Oncology
- A Small-Molecule p53 Activator Induces Apoptosis through Inhibiting MDMX Expression in Breast Cancer Cells
- (2015) Hongbo Wang et al. NEOPLASIA
- p53-Independent Roles of MDM2 in NF-κB Signaling: Implications for Cancer Therapy, Wound Healing, and Autoimmune Diseases
- (2015) Dana Thomasova et al. NEOPLASIA
- The regulation of MDM2 oncogene and its impact on human cancers
- (2014) Y. Zhao et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- FL118 Induces p53-Dependent Senescence in Colorectal Cancer Cells by Promoting Degradation of MdmX
- (2014) X. Ling et al. CANCER RESEARCH
- The anaphase-promoting complex/cyclosome is an E3 ubiquitin ligase for Mdm2
- (2014) Yizhou He et al. CELL CYCLE
- Identification of a New Class of MDM2 Inhibitor That Inhibits Growth of Orthotopic Pancreatic Tumors in Mice
- (2014) Wei Wang et al. GASTROENTEROLOGY
- The Splicing Factor FUBP1 Is Required for the Efficient Splicing of OncogeneMDM2Pre-mRNA
- (2014) Aishwarya G. Jacob et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mdmx promotes genomic instability independent of p53 and Mdm2
- (2014) A M Carrillo et al. ONCOGENE
- Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase
- (2014) C Xu et al. ONCOGENE
- Inhibition of MDM2 by Nilotinib Contributes to Cytotoxicity in Both Philadelphia-Positive and Negative Acute Lymphoblastic Leukemia
- (2014) Hailong Zhang et al. PLoS One
- The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models
- (2014) Wei Wang et al. Nature Communications
- Non-degradative ubiquitination of the Notch1 receptor by the E3 ligase MDM2 activates the Notch signalling pathway
- (2013) Susanne Pettersson et al. BIOCHEMICAL JOURNAL
- Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery
- (2013) M. Bezzi et al. GENES & DEVELOPMENT
- MDM2’s social network
- (2013) R Fåhraeus et al. ONCOGENE
- A Network of Substrates of the E3 Ubiquitin Ligases MDM2 and HUWE1 Control Apoptosis Independently of p53
- (2013) M. Kurokawa et al. Science Signaling
- Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development
- (2013) Binh Vu et al. ACS Medicinal Chemistry Letters
- Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis
- (2013) Tongsen Zheng et al. Nature Communications
- Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
- (2012) Kristiaan Lenos et al. CANCER RESEARCH
- S-MDM4 mRNA overexpression indicates a poor prognosis and marks a potential therapeutic target in chronic lymphocytic leukemia
- (2012) Ling Liu et al. CANCER SCIENCE
- Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers
- (2012) Pavlina Dolezelova et al. CELL CYCLE
- Natural Product MDM2 Inhibitors: Anticancer Activity and Mechanisms of Action
- (2012) J.-J. Qin et al. CURRENT MEDICINAL CHEMISTRY
- A 40-bp insertion/deletion polymorphism in the constitutive promoter of MDM2 confers risk for hepatocellular carcinoma in a Chinese population
- (2012) Dong Dong et al. GENE
- Mutant p53: one name, many proteins
- (2012) W. A. Freed-Pastor et al. GENES & DEVELOPMENT
- Integration of DNA Damage and Repair with Murine Double-Minute 2 (Mdm2) in Tumorigenesis
- (2012) Jason Lehman et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transcription Factor NFAT1 Activates themdm2Oncogene Independent of p53
- (2012) Xu Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice
- (2012) Shrikant R. Mulay et al. KIDNEY INTERNATIONAL
- MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability
- (2012) E Xu et al. ONCOGENE
- MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk
- (2012) Stian Knappskog et al. PLoS One
- Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts
- (2011) Cyrus Chargari et al. CANCER LETTERS
- MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity
- (2011) Maren H. Stindt et al. CELL CYCLE
- UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53
- (2011) Hong Wu et al. NATURE MEDICINE
- The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
- (2011) L. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors
- (2011) A V Vaseva et al. Cell Death & Disease
- Discovery of Mdm2-MdmX E3 Ligase Inhibitors Using a Cell-Based Ubiquitination Assay
- (2011) A. G. Herman et al. Cancer Discovery
- Phosphorylation by Casein Kinase I Promotes the Turnover of the Mdm2 Oncoprotein via the SCFβ-TRCP Ubiquitin Ligase
- (2010) Hiroyuki Inuzuka et al. CANCER CELL
- A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development
- (2010) Sean M. Post et al. CANCER CELL
- Specific inhibition of Mdm2-mediated neddylation by Tip60
- (2010) Christoph Dohmesen et al. CELL CYCLE
- Single-Nucleotide Polymorphisms in p53 Pathway and Aggressiveness of Prostate Cancer in a Caucasian Population
- (2010) T. Sun et al. CLINICAL CANCER RESEARCH
- Regulation of MDM4
- (2010) Michael et al. Frontiers in Bioscience-Landmark
- The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor
- (2010) J. J. Manfredi GENES & DEVELOPMENT
- HDMX-L Is Expressed from a Functional p53-responsive Promoter in the First Intron of theHDMXGene and Participates in an Autoregulatory Feedback Loop to Control p53 Activity
- (2010) Anna Phillips et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Turning the RING Domain Protein MdmX into an Active Ubiquitin-Protein Ligase
- (2010) Saravanakumar Iyappan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Small-Molecule Inhibitor of MDMX Activates p53 and Induces Apoptosis
- (2010) H. Wang et al. MOLECULAR CANCER THERAPEUTICS
- NF- B inhibits T-cell activation-induced, p73-dependent cell death by induction of MDM2
- (2010) V. Busuttil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The p53 orchestra: Mdm2 and Mdmx set the tone
- (2010) Mark Wade et al. TRENDS IN CELL BIOLOGY
- Signaling to p53: Ribosomal Proteins Find Their Way
- (2009) Yanping Zhang et al. CANCER CELL
- Rapamycin increases the p53/MDM2 protein ratio and p53-dependent apoptosis by translational inhibition of mdm2 in cancer cells
- (2009) Chia-Li Kao et al. CANCER LETTERS
- Mdm2-mediated ubiquitylation: p53 and beyond
- (2009) J-C Marine et al. CELL DEATH AND DIFFERENTIATION
- MDM4 (MDMX) and its Transcript Variants
- (2009) F. Mancini et al. CURRENT GENOMICS
- Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase
- (2009) Koji Okamoto et al. FEBS LETTERS
- Regulation of Expression of the Rat Orthologue of Mouse Double Minute 2 (MDM2) by H2O2-induced Oxidative Stress in Neonatal Rat Cardiac Myocytes
- (2009) Sampsa Pikkarainen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IFN Regulatory Factor 8 Regulates MDM2 in Germinal Center B Cells
- (2009) J. X. Zhou et al. JOURNAL OF IMMUNOLOGY
- ELF4/MEF Activates MDM2 Expression and Blocks Oncogene-Induced p16 Activation To Promote Transformation
- (2009) G. Sashida et al. MOLECULAR AND CELLULAR BIOLOGY
- Chemotherapy induces NEDP1-mediated destabilization of MDM2
- (2009) I R Watson et al. ONCOGENE
- CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53
- (2009) D. Shi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The regulation of MDM2 by multisite phosphorylation—Opportunities for molecular-based intervention to target tumours?
- (2009) David W. Meek et al. SEMINARS IN CANCER BIOLOGY
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
- (2009) M. Olivier et al. Cold Spring Harbor Perspectives in Biology
- Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans
- (2008) K Linke et al. CELL DEATH AND DIFFERENTIATION
- Regulation of MDMX Expression by Mitogenic Signaling
- (2008) D. M. Gilkes et al. MOLECULAR AND CELLULAR BIOLOGY
- Mdm2 and Mdm4 Loss Regulates Distinct p53 Activities
- (2008) J. A. Barboza et al. MOLECULAR CANCER RESEARCH
- Targeting tumor cells expressing p53 with a water-soluble inhibitor of Hdm2
- (2008) J. Kitagaki et al. MOLECULAR CANCER THERAPEUTICS
- Regulation of Peroxisome Proliferator–Activated Receptor-α by MDM2
- (2008) Lakshmi Gopinathan et al. TOXICOLOGICAL SCIENCES
- Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
- (2007) Sander Kersten PPAR Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started